OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Wei Gao, Zhao Huang, Jiufei Duan, et al.
Molecular Oncology (2021) Vol. 15, Iss. 12, pp. 3527-3544
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 457

Cuproptosis: mechanisms and links with cancers
Jiaming Xie, Yannan Yang, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 384

Copper metabolism in cell death and autophagy
Qian‐Li Xue, Rui Kang, Daniel J. Klionsky, et al.
Autophagy (2023) Vol. 19, Iss. 8, pp. 2175-2195
Open Access | Times Cited: 288

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Peijie Zheng, Chuntao Zhou, Liuyi Lu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 166

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Nidhi Jyotsana, Kenny T. L. Ta, Kathleen E. DelGiorno
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 140

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 117

Targeting cuproplasia and cuproptosis in cancer
Daolin Tang, Guido Kroemer, Rui Kang
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 370-388
Closed Access | Times Cited: 101

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 94

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies
Xidi Wang, Miao Zhou, Yu Liu, et al.
Cancer Letters (2023) Vol. 561, pp. 216157-216157
Closed Access | Times Cited: 77

Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death
Yu Li, Yuhui Du, Yujie Zhou, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62

Copper in cancer: from limiting nutrient to therapeutic target
Xiaolong Tang, Zaihua Yan, Yandong Miao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 52

Copper homeostasis and cuproptosis in cancer immunity and therapy
Wei‐Qing Liu, Wanrong Lin, Yan Li, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 211-227
Open Access | Times Cited: 50

Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 45

Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies
Shengjie Yang, Yujuan Li, Zhou Li-jun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26

Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24

The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm
Thi Thuy Tien Vo, Tzu‐Yu Peng, Thi Hong Nguyen, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24

Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy
Chloe Springer, Danish Humayun, Rachid Skouta
Cancers (2024) Vol. 16, Iss. 3, pp. 647-647
Open Access | Times Cited: 22

Copper and Copper Complexes in Tumor Therapy
Yingqiao Wang, Tingxi Tang, Yi Yuan, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Open Access | Times Cited: 21

Deadly excess copper
J. Sailer, Judith Nagel, Banu Akdogan, et al.
Redox Biology (2024) Vol. 75, pp. 103256-103256
Open Access | Times Cited: 20

Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
Yuhong Wang, Pei Pei, Kai Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 19

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18

Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights
K.M. Abdullah, Jyoti Kaushal, Simran Takkar, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27496-e27496
Open Access | Times Cited: 16

Ferroptosis as a mechanism of non-ferrous metal toxicity
Michael Aschner, Anatoly V. Skalny, Airton C. Martins, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 9, pp. 2391-2417
Closed Access | Times Cited: 63

Page 1 - Next Page

Scroll to top